• Boosting Protein with Role in Getting Nutrients to Cells Prevented Muscle Wasting in ALS Mice, Study Finds
  • Right to Try vs. Right to Say No: An Open Letter to Lawmakers
  • Ibudilast Added to Rilutek Improves Function in ALS Patients, Phase 2 Trial Shows
  • Phase 3 Trial of Oral Levosimendan as Respiratory Treatment for ALS Recruiting in US, Europe and Australia
  • 2 miRNAs Controlling Genes Involved in ALS, and Possible Way of Regulating Them, Identified in Study
  • FDA Approves Xeomin for Excessive Drooling, Common in ALS Patients
  • NurOwn Now Being Produced at 2nd U.S. Manufacturing Site, Brainstorm Announces
  • Minding Your Health While Living with ALS
  • Skyhawk and Celgene Partner to Develop Innovative Treatments for ALS, Other Diseases
  • Mighty Mind Strategies for Managing Pain 
  • Global Project MinE Aims to Identify Rare Gene Variants in ALS
  • Brainstorm Decides Not to Offer Investigational ALS Therapy NurOwn Under Right to Try Law